Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-alanyl-D-alanine (D-Ala-D-Ala) terminus is a critical structural motif found at the end of the peptidoglycan pentapeptide chain in Gram-positive bacteria [1]. This terminus serves as the essential substrate for transpeptidase enzymes, also known as penicillin-binding proteins (PBPs), which facilitate the cross-linking of peptidoglycan layers to provide mechanical strength and osmotic stability to the bacterial cell wall [2]. It is the primary molecular target for glycopeptide antibiotics like vancomycin, which bind to the terminus with high affinity and sterically hinder the enzymes responsible for cell wall synthesis [1,3]. Because this specific D-amino acid configuration is unique to bacteria and absent in eukaryotic cells, it provides a high degree of selective toxicity for antimicrobial therapy [2]. However, bacterial resistance can emerge through the enzymatic modification of this terminus to D-alanyl-D-lactate or D-alanyl-D-serine, which drastically reduces the binding affinity of glycopeptides and renders the drugs ineffective [1,2].
Glycopeptide antibiotics bind to the D-Ala-D-Ala terminus of the peptidoglycan precursor via five hydrogen bonds, sterically inhibiting the transglycosylation and transpeptidation reactions required for cell wall assembly [1,2].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-alanyl-D-alanine terminus of peptidoglycan pentapeptide (D-Ala-D-Ala).